| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.005 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |